Der observeredes større behandlingseffekt i undergruppen af patienter med fortrinsvis klassisk CNV læsion (N=243; Visudyne 159 og placebo 84).
The subgroup of patients with predominantly classic CNV lesions (N=243; Visudyne 159, placebo 84) were more likely to exhibit a larger treatment benefit.